Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.
Nature. 2016 Nov 17;539(7629):443-447. doi: 10.1038/nature20554. Epub 2016 Nov 9.
Nature. 2016.
PMID: 27828943
Free PMC article.
The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies.
Faia K, White K, Murphy E, Proctor J, Pink M, Kosmider N, McGovern K, Kutok J.
Faia K, et al. Among authors: kosmider n.
PLoS One. 2018 Aug 1;13(8):e0200725. doi: 10.1371/journal.pone.0200725. eCollection 2018.
PLoS One. 2018.
PMID: 30067771
Free PMC article.
Item in Clipboard
Cite
Cite